These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31154348)

  • 1. Methotrexate and doxycycline interaction: a rare cause of pancytopenia.
    Arslan A; Zain MA; Mukhtar M; Ullah W; Roomi S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics related to methotrexate-induced pancytopenia.
    Ohosone Y; Okano Y; Kameda H; Hama N; Mimori T; Akizuki M; Ikeda Y
    Clin Rheumatol; 1997 May; 16(3):321-3. PubMed ID: 9184276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
    Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
    Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose methotrexate-induced pancytopenia.
    Preet Singh Y; Aggarwal A; Misra R; Agarwal V
    Clin Rheumatol; 2007 Jan; 26(1):84-7. PubMed ID: 16636937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.
    Mofredj A; Baraka D; Charoud A
    Ann Pharmacother; 2002; 36(7-8):1295. PubMed ID: 12086573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors.
    Mameli A; Barcellona D; Marongiu F
    Am J Ther; 2017; 24(1):e106-e107. PubMed ID: 27574942
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
    Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
    Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
    PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for rheumatoid arthritis patients who are on hemodialysis.
    Al-Hasani H; Roussou E
    Rheumatol Int; 2011 Dec; 31(12):1545-7. PubMed ID: 21833520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.